Padcev 20 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FT6DY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,561
Award facts
- Contract value 100% obligated
- $24,560.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,560.88 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials. This firm fixed-price, competitively awarded contract was issued on January 30, 2026, with an ultimate completion date of February 23, 2026. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $1 billion pharmaceutical supply vehicle (valued through December 2026) that enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company was selected through open competition with no set-aside designation, demonstrating its capability to meet federal requirements on a competitive basis. Padcev (ado-trastuzumab emtansine) is an oncology medication used in cancer treatment, reflecting the company's extensive portfolio of specialty pharmaceuticals across multiple therapeutic domains including oncology, diabetes management, pain control, and neurological conditions that support military treatment facilities and veterans' healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT6DY?
SPE2DR26FT6DY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FT6DY worth?
The government has obligated $24,561 on SPE2DR26FT6DY.
Is contract SPE2DR26FT6DY an order under another contract?
Yes. SPE2DR26FT6DY is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT6DY competed?
The extent of competition for SPE2DR26FT6DY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award